Ser816

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Ser816 - MED1 (human)

Site Information
DSSSSGHsQSTLFDS SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 11952938

In vivo Characterization
Methods used to characterize site in vivo:	immunoprecipitation ( 1 ) , mass spectrometry ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:	HeLa (cervical) ( 1 )

Upstream Regulation
Putative in vivo kinases:	ATM (human) ( 1 )
Treatments:	hydroxyurea ( 1 ) , ionizing_radiation ( 1 )

References
1	Mu JJ, et al. (2007) A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints. J Biol Chem 282, 17330-4 17478428 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.